At 6.9x earnings and 6.8x forward earnings, the market is clearly pricing ADAM as a no-growth, elevated-risk mortgage REIT, not a compounder. The 0.8x price-to-book suggests discounted asset expectations, but the Altman Z-Score of 0 is a flashing distress signal that overwhelms the superficially cheap multiple. With Return on Equity at just 4.70% and an operating margin of 7.10%, profitability is thin relative to the leverage inherent in mortgage REIT models. This is not a growth story; it is a balance-sheet risk story trading at a low multiple because the market questions durability, not because it has missed explosive upside.